New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

12

FDA approves first gene therapy for adults with Hemophilia B

Hemgenix is an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

13

The role of digital health platforms in managing outbreaks

For years digital health platforms have been integral in helping navigate viral outbreaks such as HIV, COVID-19, and monkeypox. Ramin Bastani, CEO of Healthvana – a platform that delivers test results and records (the company just surpassed 50 million records delivered) to get patients on the right track to receive treatment – talks about how such digital health solutions are improving the response to disease outbreaks.

15

Teva, AbbVie finalize $6.6 billion U.S. opioid settlements

Under the deals, first announced in July, Israel-based Teva will pay up to $4.25 billion, including a supply of the overdose drug naloxone. AbbVie will pay up to $2.37 billion. The final amounts of the settlements will depend on how many state and local governments opt into them.